Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguardin...
Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguardin...
NICE focuses on depression in chronic ill healthIdentifying and treating depression in adults with chronic physical health problems (including neurological disorders) is highlighted in a new clinical guideline from the National Institute for Health and Clinical Excellence (NICE).1 The new guideline is...
(forexample,oralisotretinoin).AlsoseetheNICEguidelinesondepressioninchildrenandyoungpeople:identifcationandmanagementforadviceonrecognition,depressioninadults:recognitionandmanagementforadviceonrecognitionandassessment,andself-harminover8s:long-termmanagementforadviceonself-harm....
1.6 Non-pharmacological management of AMD StrStrategies to slow the progression of AMDategies to slow the progression of AMD 1.6.1 Do not offer thermal laser therapy (for example, argon, diode) for treating drusen in people with early AMD. Supporting people with AMD and visual impairment...
The current paper presents an analysis of the NICE guidelines on depression and attention deficit hyperactivity disorder (ADHD) from the perspective of the... J Moncrieff,S Timimi - 《Anthropology & Medicine》 被引量: 19发表: 2013年 Medication options when treating children and adolescents with AD...
technology in the NHS, as well as the cost-effectiveness of its services. NICE co-ordinates the National Collaborating Centres from whom it commissions the development of clinical practice guidelines, gives advice on best clinical practice to the NHS and produces and disseminates clinical guidelines...
NICE is now backing NHS use of Tecentriq (atezolizumab) with nab-paclitaxel for treating PD L1-positive, triple-negative, advanced breast cancer, following an “improved offer” from drugmaker Roche. In draft guidelines, the Institute said its earlier rejection has been overturned after the c...
Without adequate vitamin D, you are likely to be susceptible to bone diseases, various cancers, depression, and heart disease. The good thing is that the human body produces vitamin D with the help of the sun. If you cannot absorb the sun rays or you have limited sun exposure, then you...
Eyding and colleagues claim that reboxetine is an ineffective and potentially harmful antidepressant, and call for the mandatory publication of trial data to exclude publication bias.1The updated guidelines from the National Institute for Health and Clinical Excellence (NICE) suggest that strong ...